The Ligamp TP53 assay for detection of minimal residual disease in head and neck squamous cell carcinoma surgical margins

Clinical Cancer Research

Volumn 15, Issue 24, 2009, Pages 7658-7665

  Poeta, M Luana ^a,h   Manola, Judith ^c   Goldenberg, David ^d   Forastiere, Arlene ^a   Califano, Joseph A ^a   Ridge, John A ^e   Goodwin, Jarrard ^f   Kenady, Daniel ^g   Saunders, John ^b   Westra, William ^a   Sidransky, David ^a   Koch, Wayne M ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b GREATER BALTIMORE MEDICAL CENTER   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^e FOX CHASE CANCER CENTER   (United States)

^f UNIVERSITY OF MIAMI   (United States)

^g UNIVERSITY OF KENTUCKY   (United States)

^h UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PROTEIN P53;

ADULT; AGED; ARTICLE; ASSAY; CANCER RECURRENCE; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; DNA DETERMINATION; DNA EXTRACTION; DNA ISOLATION; FALSE POSITIVE RESULT; FEMALE; GENE AMPLIFICATION; GENE MUTATION; GENE TARGETING; HEAD AND NECK CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; MINIMAL RESIDUAL DISEASE; OVERALL SURVIVAL; PLASMID; PREDICTION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; TUMOR RECURRENCE;

EID: 73349118750     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-09-1433     Document Type: Article

References (24)

1. van Houten VM, Leemans CR, Kummer JA, et al. Molecular diagnosis of surgical margins and local recurrence in head and neck cancer patients: a prospective study. Clin Cancer Res 2004;10:3614-20.
2. Leemans CR, Tiwari R, Nauta JJ, van der Waal I, Snow GB. Recurrence at the primary site in head and neck cancer and the significance of neck lymph node metastases as a prognostic factor. Cancer (Phila) 1994;73:187-90.
3. Partridge M, Li SR, Pateromichelakis S, et al. Detection of minimal residual cancer to investigate why oral tumors recur despite seemingly adequate treatment. Clin Cancer Res 2000;6:2718-25.
4. Haque R, Contreras R, McNicoll MP, Eckberg EC, Petitti DB. Surgical margins and survival after head and neck cancer surgery. BMC Ear Nose Throat Disord 2006;6:2.
5. Bradley PJ, MacLennan K, Brakenhoff RH, Leemans CR. Status of primary tumour surgical margins in squamous head and neck cancer: prognostic implications. Curr Opin Otolaryngol Head Neck Surg 2007;15:74-81.
6. van Houten VM, Tabor MP, van den Brekel MW, et al. Mutated p53 as a molecular marker for the diagnosis of head and neck cancer. J Pathol 2002;198:476-86.
7. Tunca B, Erisen L, Coskun H, Cecener G, Ozuysal S, Egeli U. P53 gene mutations in surgical margins and primary tumor tissues of patients with squamous cell carcinoma of the head and neck. Tumori 2007;93:182-8.
8. van Houten VM, Tabor MP, van den Brekel MW, et al. Molecular assays for the diagnosis of minimal residual head-and-neck cancer: methods, reliability, pitfalls, and solutions. Clin Cancer Res 2000;6:3803-16, Review.
9. Taylor D, Koch WM, Zahurak M, Shah K, Sidransky D, Westra WH. Immunohistochemical detection of p53 protein accumulation in head and neck cancer: correlation with p53 gene alterations. Hum Pathol 1999;30:1221-5.
10. Sjögren S, Inganäs M, Norberg T, et al. The p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohistochemistry. J Natl Cancer Inst 1996;88:173-82.
11. Whetsell LH, Ringer DP, Schaefer FV. Molecular approach to rapid assessment of p53 tumor suppressor mutations in esophageal tumors from stained histological slides. Diagn Mol Pathol 1994;3:132-41.
12. Vary CP, Carmody M, LeBlanc R, Hayes T, Rundell C, Keilson L. Allele-specific hybridization of lipoprotein lipase and factor-V Leiden missense mutations with direct label alkaline phosphatase-conjugated oligonucleotide probes. Genet Anal 1996;13:59-65.
13. Harden SV, Thomas DC, Benoit N, et al. Realtime gap ligase chain reaction: a rapid semiquantitative assay for detecting p53 mutation at low levels in surgical margins and lymph nodes from resected lung and head and neck tumors. Clin Cancer Res 2004;10:2379-85.
14. Huang X, Pateromichelakis S, Hills A, et al. p53 mutations in deep tissues are more strongly associated with recurrence than mutation-positive mucosal margins. Clin Cancer Res 2007;13: 6099-106.
15. Brennan JA, Mao L, Hruban RH, et al. Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. N Engl J Med 1995;332:429-35.
16. Shi C, Eshleman SH, Jones D, et al. LigAmp for sensitive detection of single-nucleotide differences. Methods 2004;1:141-7, Epub 2004 Oct 21.
17. Poeta ML, Manola J, Goldwasser MA, et al. TP53 mutations and survival in squamous-cell carcinoma of the head and neck. N Engl J Med 2007;357:2552-61.
18. Cox DR. Analysis of Binary Data. London, England: Methuen & Co, Ltd.; 1970.
19. Wilcoxon F. Individual comparisons by ranking methods. Biometrics 1945;1:80-3.
20. Breiman L, Friedman J, Stone CJ, Olshen RA. Classification and Regression Trees. Pacific Grove (CA): Wadsworth, Inc.; 1984.
21. Peto R, Peto J. Asymptotically efficient rank invariant test procedures. J R Stat Soc Ser A 1972; 135:185-206.
22. Gray RJ. A class of k-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988;16:1141-54.
23. Zhou S, Kachhap S, Sun W, et al. Frequency and phenotypic implications of mitochondrial DNA mutations in human squamous cell cancers of the head and neck. Proc Natl Acad Sci U S A 2007;104:7540-5, Epub 2007 Apr 24.
24. Carvalho AL, Jeronimo C, Kim MM, et al. Evaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinoma. Clin Cancer Res 2008;14:97-107.